Navigation Links
Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
Date:2/23/2011

ive diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis has designed and executed a patent strategy that has provided the Company with strong and extensive protection for Isis' drugs as well as all aspects of antisense drug discovery, development and manufacturing.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis Pharmaceuticals and the discovery, development and potential of ISIS-CRPRx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015   Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform ... heart failure, and arterial disease, today announced that ... Board of Directors. Mr. Lief made this decision ... his role as President and Chief Executive Officer ...
(Date:5/28/2015)... DEKALB, Ill. , May 28, 2015 ... Intent to explore an affiliation with Northwestern Memorial ... and NMHC will further define the affiliation, which ... "KishHealth is recognized for their commitment to ... Dean M. Harrison , President and Chief Executive ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Aspects"  to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... individualized treatment is to match the right ... some cases, even to design the appropriate ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Reportlinker.com announces that a new ... Prostate Cancer - Italy Drug Forecasts and ... Prostate Cancer - Italy Drug Forecasts ... pharmaceutical report, "Prostate Cancer - Italy Drug Forecasts and ...
... 2010 Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery research, today announced ... to acquire privately-held Cambridge Research & Instrumentation, Inc. ...  CRi,s patented preclinical and tissue-based multiplexed analysis systems ...
Cached Medicine Technology:Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 2Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 3Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 4Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 5Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 6Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 7Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 8Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 9Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 10Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 11Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 12Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 13Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 14Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 2Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 3Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 4Caliper Life Sciences to Acquire Cambridge Research & Instrumentation 5
(Date:5/28/2015)... Recently, KORT Richmond, 5006 Atwood Drive, added a new ... life. The program works with those new to prosthetic devices ... are still having difficulty. , According to the Amputee ... limb loss in the United States. The main causes of ... arterial disease – trauma (45%) and cancer (less than 2%), ...
(Date:5/28/2015)... The partners of Urgent Care of Westchester and ... Almendral as their chief provider for advanced beauty treatments. ... opened facility’s plan to offer all of Westchester County ... Almendral is a board certified physician who is trained ... techniques. Her areas of expertise include Botox, Dermal Fillers, ...
(Date:5/28/2015)... 2015 On Sunday, June 21, 2015, ... team event to honor the strength, passion and endurance ... solstice, the duration of this sunrise-to-sunset event symbolizes the ... their caregivers. Participants raise funds and awareness to advance ... Association. , Teams are encouraged to create their own ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 ... has announced an exclusive deal to patients looking to ... June 1 through 30, patients will be able to ... $800 procedure, for just $600. For a three-treatment package, ... fourth treatment at no cost. , Dr. Juanita Jenyons, ...
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO , today announced ... of president. , “ Bill Taaffe has a proven ... Flanagan, Medelis’ CEO and co-founder. “He will be a great ... growth.” , Taaffe joined ICON’s U.S. clinical operations in ... 4,500 employees, achieving 12 consecutive years of growth and regional ...
Breaking Medicine News(10 mins):Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2
... ... on Friday, January 29 by Avalere Health, a Washington D.C.-based strategic and analytic consulting ... faced by the individual and small group markets in the purchase of health insurance. ... , ...
... , LOS ANGELES , Feb. 2 , ... touched even the youngest among us and we now see children taking ... early to start your kids on the right track to good health. ... on finding time to make delicious, affordable, and healthy meals for your ...
... day create exposure equal to inhaling nearly 3 more, study ... to the risks associated with directly inhaling cigarette smoke, smokers ... say. , The finding, published online Jan. 29 in ... threat posed to smokers by secondhand smoke is negligible. , ...
... ... The Accomplishing More With Less Workbook paperback and Kindle Edition at ... Manage Focused and Collaborative Time”, which is available for download at ... better manage the increasingly challenging work conditions and develop the skills ...
... , YONKERS, N.Y. ... area vary dramatically in terms of how well their intensive ... disability, and expense in our nations, hospitals that is largely preventable.  ... infection rates for 25 Boston area hospitals, along with ...
... ... hospital infection rates, a first for consumers , YONKERS, N.Y. ... expose patients to deadly central-line bloodstream infections despite the availability of a ... investigative article in the March issue of Consumer Reports . ...
Cached Medicine News:Health News:$7 Billion Potential Savings in Healthcare Reform 2Health News:$7 Billion Potential Savings in Healthcare Reform 3Health News:February Is Heart Month: These 4 Great Show Ideas Will Keep Your Audience Tuned In 2Health News:February Is Heart Month: These 4 Great Show Ideas Will Keep Your Audience Tuned In 3Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 2Health News:People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book 3Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 2Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 3Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 4Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 5Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 6Health News:Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting 7Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 2Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 3Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 4Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 5Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 6Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 7Health News:Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist 8
Only Mobile Instrument offers complete repair and rebuild capability on all makes and models of endoscopy and laparoscopy instruments, using only factory-quality parts and precision techniques....
... Olympus fiber and video scopes including bronchoscopes, ... in OR and endoscopy. Quality is of ... exceed the standards of the OEM. We ... against defects in materials and workmanship. Quotes ...
Inquire...
... carefully inspects your camera upon arrival.,Our technician then ... provides you with a thorough customer quote. We ... tight budget so well help you prioritize repairs. ... repair begins., , ISI uses only OEM or ...
Medicine Products: